WOMEN AND HEART DISEASE; ED. BY NANETTE KASS WENGER

Despite media attention and public awareness, recent advances in pharmaceutical and medical developments, heart disease in women is under-diagnosed, under-treated, and under-managed. Many women fail to present in the clinic when symptomatic, because of responsibilities at home or at work. Often the first presentation follows a cardiac event. Women are excluded from many clinical trials regardless of age or cardiac history, simply because most trials are aimed at male patients. This best-selling, updated title, aimed at changing this treatment of women's cardiac issues, covers all aspects of female cardiovascular disease. It is required reading for all practitioners who assess female patients. Epidemiology of coronary heart disease in women Cardiovascular disease risk factors in women The A, B, C, D, and E of diabetes and heart disease in women Lipid abnormalities: recognition and management Other risk interventions: smoking Other risk interventions: obesity Other risk interventions: exercise Serum homocysteine and coronary heart disease Novel risk factors: C-reactive protein Diagnostic procedures: exercise testing/exercise and pharmacologic radionuclide procedures Diagnostic procedures: stress echocardiography The role of CMR and PET in women Diagnostic procedures: electron beam tomography and multislice computed tomography Stable angina pectoris (recognition and management) Cardiac syndrome X Silent ischemia in women Acute coronary syndromes - thrombolysis, angioplasty Acute coronary syndromes Percutaneous coronary interventions in women Coronary artery bypass graft (CABG) surgery Cardiac rehabilitation for women Cardiac disease and cardiac surgery in pregnancy Hypertension in pregnancy Peripartum cardiomyopathy Sex hormones and normal cardiovascular physiology in women Menopausal hormone therapy Polycystic ovary syndrome Diastolic dysfunction Heart failure in women Cardiac transplantation Hypertension Women and congenital heart disease Acquired valvular heart disease Severe pulmonary hypertension Anorectic drugs and their cardiopulmonary effects Women, their hearts and their strokes Arrhythmia and arrhythmia management Perpheral arterial disease in women Gender and cardiovascular medications Social stress, strain, and heart disease in women Depression and heart disease Clinical trial evidence for women's cardiovascular health: what we know and what we must learn Education of women about cardiovascular health. Information about coronary heart disease (CHD) and cardiovascular disease in women is rapidly escalating, likely as a component of the concept of sex-specific medicine during the past decade. Medical reports and public information about women and heart disease now proliferate and the under-representation of women in clinical trials is reversing. New sex-specific clinical data are being published. In this second edition of Women & Heart Disease, Nanette Kass Wenger and Peter Collins present contributions from 81 international leaders in women's cardiovascular health and disease, offering a concise and well-referenced resource in 43 chapters to the practicing physician that incorporates all the latest information. It is this emerging new information about cardiovascular disease in women, and its application in daily clinical practice, which is likely to improve clinical cardiovascular outcomes for women. Despite being one of the world's biggest killers of women, heart disease is under-diagnosed, under-treated, and under-managed. Why? What is going wrong?Important and ground-breaking, Women and Heart Disease brings our attention to the inadequacies in both the diagnosis and treatment of heart disease in women.Key features:• written by Nanette Wenger and Peter Collins, two of the worlds leading cardiologists• contributions from leaders in women‘s cardiac health• covers all aspects of cardiovascular disease, not just coronary artery disease• fully updated.Building on the success of the best-selling first edition, this is essential reading for all physicians with a particular interest in women and heart disease. Fully update, this new edition covers all aspects of cardiovascular disease and not just coronary heart disease. It is requisite reading for all those physicians who have a particular interest in women and heart disease Coronary heart disease (CHD) is the leading cause of death and a major cause of disability in industrialized countries; it is rapidly also becoming the leading cause of death in non-industrialized countries. Rev. ed. of: Women and heart disease. 1997.